ロード中...
Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation
BACKGROUND: The clinical use of chromatin-modulating drugs, such as histone deacetylase inhibitors, for the treatment of bone marrow failure and hematopoietic malignancies has increased dramatically over the last few years. Nonetheless, little is currently known concerning their effects on myelopoie...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ferrata Storti Foundation
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2895027/ https://ncbi.nlm.nih.gov/pubmed/20107159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.008870 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|